Sarah B. Brand
Sarah B. Brand publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Economics and Econometrics, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
- World rank
- #2,018,432 of 7,710,434 ranked researchers
- Rank in United States
- #612,265 of 1,627,098
- Works
- 27
- Citations
- 387
- Citations per work
- 14.3
What does Sarah B. Brand research?
Sarah B. Brand's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (8%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1349.3%
- Medicine1349.3%
- Everything else1037.2%
- Life Sciences27.5%
- Social Sciences26.0%
- 1Endocrinology, Diabetes and Metabolism34% of their works
- 2Molecular Biology8% of their works
- 3Economics and Econometrics6% of their works
- 4Cardiology and Cardiovascular Medicine6% of their works
- 5Infectious Diseases4% of their works
- 6Neurology4% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Systems, Economic Evaluations, Quality of Life
- melanin and skin pigmentation
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Hormonal Regulation and Hypertension
Which keywords describe Sarah B. Brand's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Heart Failure, Cardiovascular Outcomes, Type 2 Diabetes, Cardiovascular Disease, Diabetes and Hypoglycemia.
- Primary Aldosteronism
- Melanin
- Atrial Fibrillation
- Aldosterone
- Cost-effectiveness Analysis
- Guidelines
- Hypoglycemia
- Cardiovascular Disease
- Cardiovascular Outcomes
- Insulin Therapy
- Glycemic Control
- Heart Failure
- Type 2 Diabetes
- Diabetes
- Critical Care
- Hyperglycemia
- Quality of Life
- Anticoagulant Therapy
- Diagnosis
- Pigmentation
- Treatment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Glycemic Control183 topics
- Insulin Therapy183 topics
- Heart Failure112 topics
- Cardiovascular Outcomes91 topic
- Type 2 Diabetes91 topic
- Cardiovascular Disease72 topics
- Diabetes51 topic
- Hypoglycemia51 topic
- Critical Care41 topic
- Guidelines42 topics
- Hyperglycemia41 topic
- Cost-effectiveness Analysis31 topic
- Quality of Life31 topic
- Aldosterone21 topic
- Anticoagulant Therapy21 topic
- Atrial Fibrillation21 topic
- Diagnosis21 topic
- Melanin21 topic
- Pigmentation21 topic
- Primary Aldosteronism21 topic
- Treatment21 topic
Where does Sarah B. Brand work?
Sarah B. Brand's main affiliation in the publication record is Ithaka Harbors, United States.
How many publications and citations does Sarah B. Brand have?
OpenAlex counts 27 works and 387 citations for Sarah B. Brand, an h-index of 11, ranking #2,018,432 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sarah B. Brand. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.